Dec 16 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE ANNOUNCES INITIATIVES TO FOCUS CORPORATE STRATEGY
* ONCOCYTE CORP- ANNOUNCED A REDUCTION IN FORCE INVOLVING
OVER 40%
OF ONCOCYTE'S WORKFORCE
* ONCOCYTE CORP- CO HAS ENTERED INTO A STOCK PURCHASE
AGREEMENT
PURSUANT TO WHICH ONCOCYTE WILL TRANSFER 70% OF ITS OWNERSHIP OF
RAZOR GENOMICS
* ONCOCYTE CORP- TRANSACTION INVOLVES TRANSFER OF ALL OF
ASSETS
AND LIABILITIES RELATED TO DETERMARX
* ONCOCYTE CORP- THIS TRANSACTION, ALONG WITH REDUCTION IN
FORCE,
WILL PREPARE US FOR MORE FOCUSED STRATEGY AND FURTHER ELONGATE
OUR CASH RUNAWAY
Source text for Eikon: ID:nGNX6KFkW6
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))